SCHEMBL3148463

SCHEMBL3148463

O=C1[N]C=C(Br)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2042013 0.74
SCHEMBL143917 0.70
SCHEMBL3148368 0.70
SCHEMBL440393 0.70
SCHEMBL8884963 0.67
SCHEMBL3357201 0.67
SCHEMBL3357209 0.67
SCHEMBL8554982 0.67
SCHEMBL545786 0.65 HKDC1 (0.33)
SCHEMBL8552885 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3284832-B1 APTAMER WITH IMPROVED RATE OF DISSOCIATION, AND NON-COVALENT APTAMER-TARGET COMPLEX THEREOF SOMALOGIC OPERATING CO INC (US) 2023-06-07 EP claimed
US-11597745-B2 β-modified phosphoric acid compound precursor, β-modified phosphoric acid compound, reaction inhibitor and medicine containing the same, and method for inhibiting reaction JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2023-03-07 US claimed
EP-3284832-A2 METHOD FOR GENERATING APTAMERS WITH IMPROVED OFF-RATES Somalogic, Inc. (US) 2018-02-21 EP claimed
EP-2933340-B1 Aptamers with uridines and/or thymidines substituted at the 5-position with a benzyl group SOMALOGIC INC (US) 2017-09-06 EP claimed
US-20170137819-A1 Method for Generating Aptamers with Improved Off-Rates SOMALOGIC, INC. 2017-05-18 US claimed
EP-2933340-A1 Chemically modified aptamers with improved off-rates Somalogic, Inc. (US) 2015-10-21 EP claimed
US-20150197753-A1 Method for Generating Aptamers with Improved Off-Rates SOMALOGIC, INC. 2015-07-16 US claimed
US-8975388-B2 Method for generating aptamers with improved off-rates SOMALOGIC, INC. (US) 2015-03-10 US claimed
US-8404830-B2 Method for generating aptamers with improved off-rates SOMALOGIC, INC. (US) 2013-03-26 US claimed
US-8076310-B2 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2011-12-13 US claimed
US-20080139566-A1 SUBSTITUTED OXETANES, METHOD OF MAKING, AND METHOD OF USE THEREOF HOWELL AMY R 2008-06-12 US claimed
JP-2007512358-A 2007-05-17 JP claimed
EP-1685127-A1 HETEROCYCLYL-SUBSTITUTED OXETANES FOR THE TREATMENT OF PROLIFERATIVE OR INFECTIOUS DISEASES The University of Connecticut (US) 2006-08-02 EP claimed
US-20050215568-A1 Substituted oxetanes, method of making, and method of use thereof UNIVERSITY OF CONNECTICUT, THE 2005-09-29 US claimed
WO-2005051944-A1 HETEROCYCLYL-SUBSTITUTED OXETANES FOR THE TREATMENT OF PROLIFERATIVE OR INFECTIOUS DISEASES UNIVERSITY OF CONNECTICUT (US) 2005-06-09 WO claimed
JP-3047045-B2 2000-05-29 JP claimed
US-6034087-A VIRICIDE AGAINST HEPATITIS B CHONG KUN DANG CORP. (KR) 2000-03-07 US claimed
US-6015886-A ANTISENSE AGENTS WITH MODIFICATIONS INCLUDING P-ALKOXY AND 2'-O-METHYL GROUPS; NUCLEASE RESISTANT, ABILITY TO ACTIVATE BACTERIAL RIBONUCLEASE H, FORM STABLE DUPLEXES WITH RNA, AND HAVE STRONG HYDROPHOBICITY FOR EFFICIENT CELLULAR UPTAKE CHEMGENES CORPORATION (US) 2000-01-18 US claimed
EP-0869953-A1 NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THEREOF CHONG KUN DANG CORP (KR) 1998-10-14 EP claimed
WO-1996012716-A1 NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THEREOF CHONG KUN DANG CORP. (KR) 1996-05-02 WO claimed